ATAD3A mediates activation of RAS-independent mitochondrial ERK1/2 signaling, favoring head and neck cancer development

Targeting mitochondrial oncoproteins presents a new concept in the development of effective cancer therapeutics. ATAD3A is a nuclear-encoded mitochondrial enzyme contributing to mitochondrial dynamics, cholesterol metabolism, and signal transduction. However, its impact and underlying regulatory mec...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Liwei Lang, Reid Loveless, Juan Dou, Tiffany Lam, Alex Chen, Fang Wang, Li Sun, Jakeline Juarez, Zhaohui Qin, Nabil F. Saba, Chloe Shay, Yong Teng
Formato: Artigo
Lenguaje:inglés
Publicado: 2022
Acceso en línea:https://doi.org/10.1186/s13046-022-02274-9
https://jeccr.biomedcentral.com/counter/pdf/10.1186/s13046-022-02274-9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!